30
Participants
Start Date
October 24, 2023
Primary Completion Date
November 30, 2027
Study Completion Date
November 30, 2028
Cabozantinib
Participants will receive cabozantinib in combination with high-dose ifosfamide for 5 cycles. If still on study therapy the participants will continue with cabozantinib monotherapy for up to 12 total cycles.
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
NOT_YET_RECRUITING
University of Pennsylvania, Philadelphia
RECRUITING
Children's Hospital Colorado, Aurora
NOT_YET_RECRUITING
University of California San Francisco, San Francisco
Collaborators (1)
Children's Hospital Colorado
OTHER
Alex's Lemonade Stand Foundation
INDUSTRY
Exelixis
INDUSTRY
Children's Hospital of Philadelphia
OTHER